Olivia L. Francis-Boyle, PhD, is an Assistant Professor in the Schools of Pharmacy and Medicine at Loma Linda University and Principal Investigator of an independent research program. She teaches immunology and endocrinology and focuses on acute leukemia mechanisms, therapeutic development, and drug modeling. Her research employs patient-derived xenograft (PDX) models, in vitro/in vivo approaches, and high-throughput sequencing. Education: PhD in Molecular Biology, Loma Linda University (2015) MS in Biomedical Science, Walden University (2011) BS in Biology, Andrews University (2005) Research Interests: Investigating cellular/molecular mechanisms of acute leukemias (AML/ALL), evaluating therapeutic candidates (biologics, small molecules, immunotherapies), and leveraging PDX models for precision medicine. Recent Article Trends: Her work spans leukemia drug development, TSLP signaling in B-ALL, and metabolic pathways in AML. Key themes include xenograft models, therapeutic screening, and molecular mechanisms. Grants & Advising: Principal Investigator: Combination anti-PD1 therapy and TILs for AML (2020-2025) Completed grants include TSLP in pediatric B-ALL (2012-2013) and Hyundai Hope on Wheels (2015-2016) Labs & Teams: Leads a lab training students/fellows in leukemia research, collaborating on preclinical drug models and translational studies.










